Deep learning-based multimodal pathogenomics integration for precision cancer prognosis.

Abstract

Authors

• Xiaobing Feng
  Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Hangzhou, 310022, China; College of Electrical and Information Engineering, Hunan University, Changsha, 410082, China.
• Ge Song
  Department of Neurosurgery, People's Hospital of Hanzhong City, Hanzhong 723000, Shaanxi, China.
• Ye Zhang
  Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China.
• Lu Guo
  Department of Radiation Oncology, Tianjin Medical University Cancer Institute & Hospital, Tianjin, PR China.
• Yian Jiang
  Zhejiang Cancer Hospital, Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Hangzhou, 310022, China.
• Wangang Gong
  Zhejiang Cancer Hospital, Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Hangzhou, 310022, China.
• Yue Feng
  Nursing School, Sichuan University, China.
• Chunwei Xu
  Department of Pathology, Fujian Cancer Hospital, Fuzhou, 350001, China.
• Yang Yang
  Department of Gastrointestinal Surgery, The Third Hospital of Hebei Medical University, Shijiazhuang, China.
• Min He
  Department of Endocrinology, Shanghai Medical School, Huashan Hospital, Fudan University, Shanghai, China.

Keywords

No keywords available for this article.

External Resources